Cancer Research Landon Prizes for Basic and Translational Cancer Research  Tumor Immunology: New Perspectives
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 52, 53-57, January 1, 1992]
© 1992 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Abrahams, P. J.
Right arrow Articles by van der Eb, A. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Abrahams, P. J.
Right arrow Articles by van der Eb, A. J.

High Levels of Enhanced Reactivation of Herpes Simplex Virus in Skin Fibroblasts from Various Hereditary Cancer-prone Syndromes1

Peter J. Abrahams, Ada Houweling and Alex J. van der Eb

Laboratory for Molecular Carcinogenesis, Sylvius Laboratories, 2300 RA Leiden, The Netherlands

The dose response of the enhanced reactivation (ER) of herpes simplex virus type 1 has been studied in UV-irradiated normal human skin fibroblasts and fibroblasts from the following hereditary cancer-prone syndromes: retinoblastoma, aniridia, polyposis coli, neurofibromatosis type 1 and 2, dysplastic nevus syndrome, Von Hippel-Lindau syndrome, multiple endocrine neoplasia type 2, and Bloom's syndrome. Surprisingly, much higher levels of ER were observed in all these genetically heterogeneous hereditary disorders than in normal human skin fibroblasts. These results suggest that loss of one allele of putative tumor suppressor genes may activate cellular processes that result in the induction of the ER response, and they support our previous observation suggesting that ER may somehow be related to the process of carcinogenesis (P. J. Abrahams et al., Cancer Res., 48: 6054–6057, 1988).

1 This work was supported by the J. A. Cohen Institute, Interuniversity Research Institute for Radiopathology and Radiation Protection, and by EEC Contract Bi.7-034.

Received 7/ 9/91. Accepted 10/18/91.




This article has been cited by other articles:


Home page
J. Virol.Home page
Y.-H. Zhang, K. Kooistra, A. Pietersen, J. L. Rohn, and M. H. M. Noteborn
Activation of the Tumor-Specific Death Effector Apoptin and Its Kinase by an N-Terminal Determinant of Simian Virus 40 Large T Antigen
J. Virol., September 15, 2004; 78(18): 9965 - 9976.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
F. Moinfar, Y. G. Man, L. Arnould, G. L. Bratthauer, M. Ratschek, and F. A. Tavassoli
Concurrent and Independent Genetic Alterations in the Stromal and Epithelial Cells of Mammary Carcinoma: Implications for Tumorigenesis
Cancer Res., May 1, 2000; 60(9): 2562 - 2566.
[Abstract] [Full Text]


Home page
Cancer Res.Home page
Y.-H. Zhang, P. J. Abrahams, A. J. van der Eb, and M. H. M. Noteborn
The Viral Protein Apoptin Induces Apoptosis in UV-C-irradiated Cells from Individuals with Various Hereditary Cancer-prone Syndromes
Cancer Res., June 1, 1999; 59(12): 3010 - 3015.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1992 by the American Association for Cancer Research.